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HIV and/or AIDS-related deaths and modifiable risk 
factors: A descriptive study of medical admissions at 
Oshakati Intermediate Hospital in Northern Namibia
Background: High rates of HIV infection have decreased life expectancy in many African 
countries. Regardless of worldwide efforts to escalate treatment, care and prevention strategies, 
the number of deaths due to AIDS-related disorders is still high. Local healthcare workers 
suspect that there are modifiable factors in the care of HIV and/or AIDS patients which can be 
identified and improved.
Aim: To describe the HIV and/or AIDS-related causes of adult mortality and identify modifiable 
factors amongst patients admitted to Oshakati Intermediate Hospital, northern Namibia.
Methods: Data was extracted retrospectively and coded using the modified CoDe protocol for 
AIDS. Modifiable factors relating to the patient, health system or clinical care were identified 
using a standardised data collection tool.
Results: A total of 177 HIV and/or AIDS patients were identified, 94 (53.1%) were male and 
120 (68%) had a CD4 count of less than 200 cells/mL. The common HIV-related causes of death 
were tuberculosis (25.9%), renal failure (15.8%), Pneumocystis jirovecii pneumonia (11.3%), 
cryptococcal meningitis (9%), HIV wasting syndrome (7.9%) and AIDS-defining malignancy 
(7.9%). The analysis revealed 281 modifiable factors; patient-related factors were the most 
common (153 [54.4%]), followed by health system factors (97 [34.5%]) and healthcare personnel 
factors (31 [11%]).
Conclusion: Our findings have highlighted the challenges in overall HIV and/or AIDS 
inpatient care and surrounding primary care facilities. The identification of specific modifiable 
factors can be used to reduce mortality by providing training as well as rational monitoring, 
planning and resource allocation.
Décès liés au VIH/SIDA et facteurs de risques modifiables: Etude descriptive des admissions 
médicales à l’Hôpital intermédiaire d’Oshakati au nord de la Namibie.
Contexte: Le taux élevé d’infection par VIH a réduit l’espérance de vie dans de nombreux 
pays africains. Malgré les efforts mondiaux d’intensification des traitements, des soins et des 
stratégies de prévention, le nombre de décès dus aux troubles associés au SIDA est encore élevé. 
Le personnel de santé local pense qu’on peut identifier et améliorer certains facteurs modifiables 
dans les soins des malades du VIH/SIDA.
Objectif: Décrire les causes de mortalité des adultes liées au VIH/SIDA et identifier les facteurs 
modifiables chez les patients admis à l’Hôpital Intermédiaire d’Oshakati, au nord de la Namibie. 
Méthodes: les données ont été extraites et classées rétrospectivement en utilisant le protocole 
modifié CoDe pour le SIDA. Les facteurs modifiables concernant le patient, le système de santé 
ou de soins cliniques ont été identifiés à l’aide d’un outil de collecte de données standardisé.
Résultats: On a identifié au total 177 malades du VIH/SIDA, dont 94 (53.1%) étaient des hommes 
et 120 (68%) avaient un taux de CD4 de moins de 200 cellules /ml. Les causes les plus fréquentes 
de décès lié au HIV étaient la tuberculose (25.9%), l’insuffisance rénale (15.8%), la pneumonie 
Pneumocystis jirovecii (11.3%), la méningite cryptococcique (9%), le syndrome de dépérissement 
lié au VIH (7.9%) et les tumeurs liées au SIDA (7.9%). L’analyse a révélé 281 facteurs modifiables; 
les facteurs liés au patient étaient les plus fréquents (153 [54.4%]), suivis des facteurs liés au 
système de santé (97 [34.5%]) et ceux liés au personnel de santé (31 [11%]). 
Conclusion: Nos résultats ont mis en évidence les défis des soins en hospitalisation des malades 
du VIH/SIDA et dans les établissements de soins primaires avoisinants. On peut utiliser 
l’identification de facteurs modifiables particuliers pour réduire la mortalité en offrant des 
formations, des contrôles rationnels ainsi que la planification et l’allocation des ressources.
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to read online.
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Introduction
HIV and/or AIDS is one of the major global public health 
problems and causes substantial morbidity, mortality, 
negative socio-economic impact, and human suffering.1,2 
Since the beginning of 1981, HIV and/or AIDS has become a 
pandemic disease, claiming some 20 million lives.1 By the end 
of 2010, an estimated 34 million people of all age groups (31.6 
million–35.2 million) were living with HIV worldwide.1,2
Sub-Saharan Africa, with only 12% of the global population, 
ranks top amongst the regions that are drastically affected 
by HIV.3 The region contributes 68% of all HIV and/or 
AIDS patients in the world, whilst South-East Asia has 12%, 
Eastern Europe and Central Asia 4%, Latin America 4% and 
North America 4%. South Africa has the highest number of 
people living with HIV and/or AIDS (having more than 4 
million patients).2
Namibia is amongst the countries which are significantly 
affected by HIV and/or AIDS. It has a relatively small 
population of 2.1 million and the Ministry of Health and 
Social Services estimates the HIV prevalence rate to be 18.2%.4 
Furthermore, in 2011–2012 it was estimated that 193 000 
adults and children were living with HIV. This number is 
predicted to increase to 196 000 in the year 2015–2016.5
The HIV and/or AIDS epidemic is the largest contributor 
to the burden of disease in Namibia, contributing 37% to 
indirect causes of maternal mortality, which is an increase 
of 50% from 2000 to 2006. Furthermore, life expectancy has 
decreased from 62 years in 1996 to 44 years in 2006 due to 
HIV and/or AIDS.4,5
Over the past two decades, the government of Namibia has 
prioritised HIV and AIDS in its development goals for 2030. 
This has led to increases in universal access to antiretroviral 
treatment, with coverage of between 50% and 80% of eligible 
patients.2
Strategies used to curb HIV and/or AIDS morbidity and 
mortality in Namibia include the provision of free, highly 
active antiretroviral therapy (HAART); recruitment, re-
training and retention of health workers; health education; 
screening for and ultimately treating opportunistic infections 
as well as sexually transmitted diseases.3,4 The screening for 
opportunistic infections and preventive therapy is offered 
by both hospitals and clinics and includes the provision 
of isoniazid, co-trimoxazole, fluconazole and malaria 
prophylaxis in pregnancy. Ongoing adherence counselling 
and the retention of patients at the clinic level may also help 
to reduce mortality and morbidity.4,5,6,7,8,9,10,11,12,13
Despite the national efforts, premature deaths from HIV and/
or AIDS continue and reflect deficiencies in quality of care at 
different levels of the health system.4 Quality improvement 
projects have directed their energy at the clinic level, where 
most of the HIV clients are clinically stable, whilst less effort 
has been directed at those admitted to hospital with acute 
conditions.5
Like any other chronic condition, the management and 
progression of HIV and/or AIDS has both non-modifiable 
and modifiable factors associated with it. Modifiable factors 
are omissions or commissions that occur during the process 
of patient care and which subsequently lead to substandard 
care. They could be related to the patient, their caregiver, 
healthcare workers or the health system.6,13
Non-modifiable risk factors include age, race and gender. 
Modifiable non-HIV specific factors include smoking 
status, body mass index, hypertension, diabetes mellitus, 
and hepatitis C and B status. Other modifiable HIV-specific 
factors include, for example, the patient’s CD4 count and 
viral load.14
There has been no formal study to assess the causes of death 
and modifiable factors related to inpatient mortality amongst 
HIV-infected patients in Namibia. Local healthcare workers 
suspect that there are many modifiable factors affecting 
patient outcomes within Oshakati Intermediate Hospital. 
Identification of these modifiable risk factors and prompt 
interventions may provide insight into how to improve the 
management of HIV and/or AIDS patients admitted in our 
hospital.14,15
The aim of the study, therefore, was to investigate the 
modifiable factors contributing to HIV and/or AIDS-related 
deaths amongst adults in Oshakati Intermediate Hospital.
Methods
Study design
This was a descriptive study using data extracted 
retrospectively from the medical records of patients who 
died of HIV-related disease.
Study setting
The study was undertaken at Oshakati Intermediate Hospital, 
which is located in Oshana region, northern Namibia. It is 
a 750-bed public hospital, serving approximately 750 000 
Namibians and an unknown number of Angolans. The region 
has no district hospital; therefore, Oshakati Intermediate 
Hospital receives referrals from local primary care clinics as 
well as district hospitals in the Omusati, Kunene, Ohangwena 
and Oshikoto regions.
Oshakati Intermediate Hospital is also a teaching hospital; 
and has relatively more staff than nearby district hospitals. 
The internal medicine department alone has four specialist 
physicians, an HIV and/or AIDS clinical mentor, two medical 
practitioners, two interns and 14 nurses. The male and female 
wards have 130 beds with three high-dependency units. 
The HAART centre, oncology clinic and medical outpatient 
department are under the umbrella of the internal medicine 
department.
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Data collection
Folders from patients who had died of HIV-related causes 
were selected for data collection and only patients with a 
confirmed HIV-positive test result were included.
An auditing team was established that consisted of the 
researcher, four specialist physicians, an HIV and/or AIDS 
clinical mentor, an intern doctor, registered nurses and one 
administrator. This team was responsible for reviewing 
patient files from medical records and determining the 
diagnoses, HIV-related death and likely modifiable factors.
Basic clinical and demographic information was extracted for 
each patient in a standardised way: age, gender, HIV status, 
HAART status, length of stay in the ward, CD4 count and 
viral load.
The diagnoses were determined after a review of the patients’ 
medical history from the patients’ health booklets, nurses’ 
notes, clinical notes made by the admitting doctors, and 
progress reports from nurses and doctors at different points 
of care such as casualty, medical outpatients, inpatients 
and referral letters. The results of investigations, such as 
laboratory results and imaging, were reviewed. Results 
which were not in the files were traced manually using the 
available requisition numbers.
To date, no validation study exist to assess HIV-related 
causes of death in Namibia: The International Classification 
of Disease, ICD1-10, has limited value. Therefore, a protocol 
for determining the HIV-related cause of death, the CoDe 
system, was adapted from the Copenhagen HIV Programme, 
Centre of Global Excellence.16 This is the standardised system 
for classifying and coding deaths in studies of patients with 
HIV infection based on detailed data collection of information 
on the causes of death and contributing factors. The World 
Health Organization’s staging system was also used to 
categorise AIDS-specific causes of death.2 When there were 
disagreements between the reviewers, a consensus agreement 
with the clinical HIV mentor was reached. The mentor is an 
employee of the International Training and Education Center 
for Health in Namibia, covering the northern region.
The team then considered potential modifiable factors 
that could be related to the patients, their caregivers, their 
healthcare workers or the performance of the health system. 
The data collection tool and process used were modelled 
on similar approaches in the Child Healthcare Problem 
Identification Programme (CHPIP system), but adapted 
to adults with HIV.15 The study supervisor independently 
assessed the construction of the tool to improve its validity.
The causes of HIV and/or AIDS-related deaths were multi-
factorial. As several factors might interact to contribute to 
deaths in this study, all modifiable factors were assessed per 
patient folder.
A pilot study was conducted to assess the quality of the 
clinical notes before the study. The study instrument was pre-
tested a week before execution of the study on the records 
of patients with HIV who had recently died at the hospital. 
After reviewing 21 files for the pilot study, questions which 
were not clear were rephrased and retested; thereafter, a 
new questionnaire was constructed and used to capture the 
appropriate data for the study.
Data analysis
All the data was captured on a purpose-designed form in 
Microsoft Access and this programme was subsequently 
used to produce a data spreadsheet in Microsoft Excel. The 
data was cleaned and verified to minimise entry errors, 
outliers and missing values. Frequencies and percentages 
were calculated for categorical data. Statisticians at the 
Centre for Statistical Consultation at Stellenbosch University 
were consulted for inferential data analysis. Inferential 
data analysis was done using the Statistical Package for 
Social Scientists software window version 19.0 (SPSS Inc., 
Chicago, IL). The frequencies and Pearson Chi square test 
were used to analyse the association between the dependent 
and independent variables and p < 0.05 was considered 
statistically significant.
Ethical considerations
The proposal was approved by the Health Research Ethics 
Committee of Stellenbosch University (S12/11/301) and the 
Oshakati Intermediate Hospital ethics committee.
Results
General characteristics of HIV-infected patients
There were 2452 admissions, in both medical wards, during 
the period from 01 January to 31 December 2011. The overall 
number of deaths was 564 (23.0%), and of these deaths 201 
(a case fatality rate of 35.7%) were documented as related to 
HIV. Out of these 201 deaths, the folders were retrieved for 
177 patients.
Of 177 audited folders, 94 (53.1%) patients were on HAART 
and 48 (51.1%) had been initiated on HAART within the 
previous 90 days. Table 1 summarises the characteristics of 
the study population.
HIV-related deaths
Amongst the patients reviewed, 82.0% died of HIV and/
or AIDS-defining conditions, whereas 18.0% had non-
AIDS-defining diseases. The underlying causes of death 
and frequencies are shown in Table 2. Extra-pulmonary 
tuberculosis accounted for most deaths, followed by renal 
failure, Pneumocystis jirovecii pneumonia, cryptococcal 
meningitis and HIV wasting syndrome.
Modifiable factors
Three broad modifiable factors were detected: patient- and 
caregiver-related factors accounted for 153 (54.4%), followed 
by healthcare system factors 97 (34.5%) and finally healthcare 
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worker-related factors 31 (11.0%). Delayed presentation 
to a health facility was the commonest factor overall 
and accounted for 85.0% of patient- or caregiver-related 
factors. Failure to provide standard critical care services, 
haemodialysis or ventilator support accounted for 86.0% 
of health system factors whereas challenges experienced 
in monitoring patients was the main factor for healthcare 
workers (29.0%). Table 3 summarises the specific modifiable 
factors.
Table 4 shows the relationship between variables and HIV 
clinical diagnosis. More male patients died of AIDS-defining 
diseases compared to females, and the difference was 
statistically significant, (57.24% versus 42.76%; p-value < 0.05), 
All age groups were at the same risk of dying either from 
AIDS-defining conditions or a non-AIDS-defining condition 
(p = 0.546). Moreover, for these two groups of patients there 
were no differences in length of hospitalisation (p = 0.99), In 
addition, more patients with CD4 counts of less than 200 cell/
mm3 died of AIDS-defining conditions than those with CD4 
counts of more than 200 cells/mm3 (75.86% versus 31.25%; 
p < 0.05). Furthermore, more patients who were on HAART 
in the study group died of a non-AIDS-defining illness than 
TABLE 1: General characteristics of the HIV-infected patients.
Characteristics All (n = 177)
n (%)
Males (n = 94)
n (%)
Females (n = 83)
n (%)
Age group (years)
15–24 22 (12) 12 (13) 10 (12)
25–44 89 (50) 44 (47) 45 (54)
45–64 55 (31) 31 (33) 24 (29)
65 11 (6) 7 (7) 4 (5)
Duration of hospital stay (days)
< 1 48 (27) 30 (62) 18 (37)
1–14 93 (52) 40 (43) 53 (57)
15–28 21 (12) 13( 62) 8 (38)
> 28 15 (8) 11 (73) 4 (27)
CD4 counts (cells/mm3)
< 200 120 (68) 64 (53) 56 (47)
200 + 57 (32) 30 (53) 27 (47)
HAART status
Pre-HAART 83 (47) 40 (48) 43 (52)
On HAART < 15 days 15 (16) 10 (67) 5 (33)
On HAART 15–90 days 33 (35) 15 (45) 18 (55)
On HAART 91–365 days 15 (16) 10 (67) 5 (33)
On HAART > 365 days 31 (33) 19 (61) 12 (39)
HAART (Total) 94 (53) 54 (57) 40 (43)
TABLE 2: HIV-related deaths.
Diagnosis n (%) (n = 177)
Extra-pulmonary tuberculosis 30 (16.9)
Renal failure 28 (15.8)
Pneumocystis pneumonia 20 (11.3)
Pulmonary tuberculosis 16 (9.0)
Cryptococcal meningitis 15 (8.5)
HIV wasting syndrome 14 (7.9)
AIDS-defining malignancies 14 (7.9)
Haematological disease 9 (5.1)
Chronic diarrhoea 8 (4.5)
CNS disease 7 (4.0)
Severe bacterial infections 5 (2.8)
Liver failure other than viral hepatitis 4 (2.3)
Alcohol abuse 3 (1.7)
Non-AIDS malignancy 2 (1.1)
Pulmonary thrombo-embolism 1 (0.6)
Cardiovascular disease 1 (0.6)
TABLE 3: Modifiable factors.
Modifiable factors  n (%)
Patient- and caregiver-related factors (N = 153)
Delayed presentation to a health facility 130 (84.9)
Defaulted HIV treatment 21 (7.4)
Alcohol abuse 2 (1.3)
Healthcare system factors (n = 97)
Lack of dialysis machine for HIV-positive patients 31 (31.9)
Inadequate respiratory support in the ward (oxygen supply) 26 (26.8)
Lack of ICU care for patient with HIV and/or AIDS 26 (26.8)
Inadequate blood product supply to the ward 6 (6.1)
Inadequate hospital stock of essential consumables 3 (3.1)
Basic laboratory investigations not available to ward 24 hours a day 2 (2.1)
Inadequate ward stock of essential consumables 1 (1.0)
Lack of standardised case management protocols in ward 1 (1.0)
Doctors in the ward inadequately supervised 1 (1.0)
Healthcare worker factors (n = 31)
Essential treatment not prescribed 4 (12.9) 
Inadequate monitoring of kidney disease 4 (12.9)
Inadequate monitoring/intervention of liver disease 3 (9.7) 
Inadequate evaluation of treatable malignancy 1 (3.2)
Inadequate assessment of fitting or comatose patient 6 (19.3)
Inadequate fluid replacement 4 (12.9) 
Insufficient case assessment and management in the ward 3 (9.7)
Inadequate switching HAART due to toxicity 2 (6.5)
Inadequate blood chemistry review 1 (3.2)
Doctor called, but did not respond 1 (3.2)
Doctor at peripheral hospital did not call referral hospital 1 (3.2)
Critical HIV patient not reviewed by doctor during weekend 1 (3.2)
TABLE 4: Association between gender and disease categorisation.
Variable Non-AIDS AIDS Total   p-value
Gender
Male 11 (34.38) 83 (57.24) 94 p = 0.019
Female 21 (65.63) 62 (42.76) 83
Total 32 145 177
Age grouping
15–24 3 (9.38) 19 (13.10) 22
25–44 15 (46.88) 74 (51.03) 89
45–64 13 (40.63) 42 (28.97) 55
65 + 1 (3.13) 10 (6.9) 11
Total 32 145 177 p = 0.546
CD4 
< 200 10 (31.25) 110 (75.86) 120
> 200 22 (68.75) 35 (24.14) 57 p < 0.01
Total 32 145 177
Duration of stay
< 1 39 (26.7) 9 (28.13) 48
1–14 77 (53.10) 16 (50.0) 93
15–28 17 (11.72) 4 (12.5) 21 p = 0.99
> 28 days 12 (8.28) 3 (9.38) 15
Total 145 32 177
HAART status
HAART 24 (75.0) 70 (48.8) 94 p = 0.006
Pre-HAART 8 (25.0) 75 (51.1) 83
Total 32 145 177
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pre-HAART patients, and the relationship is statistically 
significant (75.00% versus 25.00%; p = 0.006).
Discussion
This study demonstrated that the overall percentage of all 
deaths in the hospital’s medical wards directly attributable 
to HIV was relatively high at 35.0%, although this finding 
was consistent with studies in similar settings.5,6,7 As some 
patients died without an established HIV diagnosis, this 
percentage is also likely to be an underestimate.
Patient-related modifiable factors played a significant role 
through delayed presentation and defaulting on treatment, 
which led to patients’ presenting with more advanced 
disease that was more difficult to treat successfully.6,7,17 
Other patient-related factors identified in the study were 
male gender, low CD4 counts of less than 200 cells/mm3 and 
pre-HAART patients, which could reflect determinants or 
predictors of HIV-related mortality. A similar trend has also 
been observed in other studies.6,7,18
 In our setup, the focus of HIV and/or AIDS prevention 
strategies is largely on the pregnant woman (83.0% coverage) 
during antenatal care and the natal and postnatal periods, 
which in turn capture more HIV and/or AIDS-infected 
woman than men. The overall HAART coverage in Namibia 
is estimated at 88.0% coverage and the country has adapted 
the updated WHO eligibility criteria to CD4 500 cell/
mm3.3,4,5 However, the mortality rate of HIV-related death 
is still high. The reasons for such late presentation and 
poor adherence identified in other studies include barriers 
to accessing care, forgetfulness, socio-economic constraints, 
fear of discrimination or stigmatisation, drug toxicity and 
limited knowledge of HIV and/or AIDS.6,7,13,15,19,20 As in 
our study, it is reported that early HIV diagnosis, early 
help-seeking behaviour, improved access to care, prompt 
initiation of HAART for eligible patients, and maintaining 
good adherence are critical to successful HIV and/or AIDS 
treatment.7,19,21,17,22,23,24 Further studies are needed to identify 
barriers to accessing care in our setting and to understand 
help-seeking behaviour in local communities.
Numerous researchers have reported significant reductions in 
mortality in HIV and/or AIDS patients after the introduction 
of HAART and attention having been given to modifiable 
factors in the quality of care.6,8,9,13,14,15,16,25,18,26,27
 Modifiable factors identified in this study have highlighted 
several areas for potential improvement in adult care, 
treatment and monitoring. In our study, patients who 
had CD4 counts of more than 200 cells/mm3 and were on 
HAART died of non-AIDS-defining diseases, whereas 
the pre-HAART group succumbed due to AIDS-related 
diseases. This reflects the efficacy of HAART in preventing 
advanced HIV and/or AIDS disease; however, long-term use 
of HAART predisposes patients to metabolic complications 
which are also detrimental, a phenomenon being observed in 
developing countries.
Within the healthcare system at the hospital, there appeared 
to be discrimination against patients with HIV in terms of 
access to intensive care beds. Such discrimination might 
be related to a shortage of ICU beds, a lack of HIV and/or 
AIDS knowledge and negative attitudes towards critically ill 
patients. Similar findings on HIV and ICU care have been 
noted in some developing countries, whilst in South Africa, 
India and Brazil there are regulatory bodies that govern 
and prevent non-discriminatory practice.28 Therefore there 
is a need for policy-makers, health system administrators 
and clinicians to devise policy frameworks or guidelines to 
ensure non-discriminatory access to ICU care regardless of 
HIV status.
A lack of dialysis for HIV-positive patients with renal failure 
contributed significantly to deaths, as such patients depend 
mainly on conservative management. The importance of 
dialysis and close monitoring of renal function in patients 
with renal impairment cannot be over-emphasised, as 
there has been a rapid increase in renal failure in the HIV 
population worldwide. The HIV virus and Tenofovir-based 
therapy are both associated with renal diseases.29 There 
appears to be a lack of insight into and prioritisation of 
procurement for patients with HIV, although discussions 
with the management team revealed plans to construct a new 
dialysis unit by 2018. In the meantime, in-service training 
for peritoneal dialysis is being conducted as a short-term 
solution.
Health system managers must also ensure that essential 
consumables such as medication are available and should 
improve the turnaround time for crucial laboratory results. 
Blood products such as platelets take 48–72 hours to arrive 
from Windhoek and there is a need to construct a blood bank 
to serve northern Namibia.
Many patients who died were eligible for HAART, which 
reflects a gap in existing strategies for the screening, 
prevention and treatment of opportunistic infections at 
primary healthcare level. There is a need for our HAART 
centres at Oshakati and surrounding district hospitals to 
implement quality improvement projects that address this 
issue.4,30
The hospital relies on many foreign-trained healthcare 
workers who may not be familiar with HIV management. 
Therefore there is a need to familiarise junior colleagues 
with local guidelines and expose them to the HAART service 
with the objective of improving their HIV and/or AIDS case 
management skills.30 Deficiencies in individual clinical care 
may be addressed by more effective continuing professional 
development as well as regular risk management meetings that 
discuss morbidity and mortality. The hospital should make 
attendance at educational meetings mandatory and ensure 
more effective interactive small-group learning as opposed to 
formal didactic approaches. Disciplinary measures should be 
taken against healthcare workers who do not follow ethical 
rules and continue to practise negligently. Several studies 
Page 6 of 7 Original Research
http://www.phcfm.org doi:10.4102/phcfm.v7i1.883
have shown that greater physician experience and expertise 
is associated with reduced patient morbidity and mortality.25,31
Not all of the medical records could be retrieved and we also 
faced challenges arising from, information being missing 
from medical records. Data on the social, demographic and 
economic status of the patients was often not available in the 
folders and therefore the effect on health-seeking practice could 
not be studied. The clinical notes in some files were written in 
poor handwriting, which made data collection difficult. The 
causes of death were based on clinical findings recorded in the 
notes and no postmortems were conducted; this was mainly 
due to social–cultural barriers. The findings from postmortem 
examinations could have better defined the causes death.
Globally there are challenges in coding HIV deaths; added 
to which the available tools do not reflect the common 
conditions affecting sub-Saharan Africa. We overcame this 
difficulty in our study by using both the WHO and the CoDe 
to capture all causes.
Conclusion
HIV and/or AIDS contributed significantly to overall inpatient 
mortality, and AIDS-defining diseases were the leading causes 
of deaths in the Oshakati Intermediate Hospital. The most 
common causes of death were extra-pulmonary tuberculosis, 
renal failure and Pneumocystis jirovecii pneumonia. Patient- 
and caregiver-related factors, particularly delays in seeking 
healthcare, were the most common modifiable factors. Access 
to critical care, dialysis and ventilator support as well as the 
poor monitoring of patients were the main modifiable factors 
in the hospital. Future studies should investigate issues related 
to the accessibility of healthcare and the initiation of HAART at 
primary care facilities. Continuing professional development, 
routine risk management, and better planning and procurement 
of essential resources will help to reduce deaths in the hospital.
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